Messina Giovanni, Atterrato Maria Teresa, Dimitri Patrizio
Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Dipartimento di Biologia e Biotecnologie "Charles Darwin", Sapienza Università di Roma, Italy.
J Med Genet. 2016 Dec;53(12):793-797. doi: 10.1136/jmedgenet-2016-103842. Epub 2016 Apr 26.
Floating-Harbor syndrome (FHS) is a rare human disease characterised by delayed bone mineralisation and growth deficiency, often associated with mental retardation and skeletal and craniofacial abnormalities. FHS was first described at Boston's Floating Hospital 42 years ago, but the causative gene, called Srcap, was identified only recently. Truncated SRCAP protein variants have been implicated in the mechanism of FHS, but the molecular bases underlying the disease must still be elucidated and investigating the molecular defects leading to the onset of FHS remains a challenge. Here we comprehensively review recent work and provide alterative hypotheses to explain how the Srcap truncating mutations lead to the onset of FHS.
弗洛廷-哈伯综合征(FHS)是一种罕见的人类疾病,其特征为骨矿化延迟和生长发育迟缓,常伴有智力障碍以及骨骼和颅面异常。42年前,FHS首次在波士顿的弗洛廷医院被描述,但直到最近才确定其致病基因Srcap。截短的SRCAP蛋白变体与FHS的发病机制有关,但该疾病的分子基础仍有待阐明,探究导致FHS发病的分子缺陷仍是一项挑战。在此,我们全面回顾了近期的研究工作,并提供了替代性假说,以解释Srcap截短突变如何导致FHS的发病。